Search Results 551-560 of 21309 for anti-TNF drugs

1. New progress in development of gene therapy for arthritis - Mayo Clinic

   Treatment of arthritis is limited by the pharmacokinetics of joints, which impede the sustained, intra-articular delivery of therapeutic agents.

2. Cyclosporine (Intravenous Route) Before Using - Mayo Clinic

   Your doctor may decide not to treat you with this medication or change some of the other medicines you take. ... Adalimumab; Adenovirus Vaccine, Live; Afatinib ...

3. Anticholinergics And Antispasmodics (Oral Route, Parenteral Route, Rectal Route, Transdermal Route) Before Using - Mayo Clinic

   Allergies. Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this group or any other medicines. Also tell your health care ...

4. Neurofibromatosis type 1 - Diagnosis and treatment - Mayo Clinic

   This genetic condition causes tumors on nerve tissue. Surgery and other therapies can manage symptoms.

5. Corticosteroid (Oral Route, Parenteral Route) Before Using - Mayo Clinic

   Corticosteroids may cause infections such as chickenpox or measles to be more serious in children who catch them. These medicines can also slow or stop growth ...

6. Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation - Mayo Clinic

   Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage ...

7. Antihemophilic Factor Viii And Von Willebrand Factor (Intravenous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Alphanate; Humate-P; Wilate. Descriptions.

8. Cyclophosphamide (Oral Route, Intravenous Route) Description and Brand Names - Mayo Clinic

   It belongs to the group of cancer medicines called alkylating agents.

9. A Study of the Use of a New Drug in People with Non-Alcoholic Steatohepatitis (NASH) or Non-Alcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

   Additionally, if subjects are taking drugs such Vit E, Ursodeoxycholic acid, Gemfibrozil, anti TNF therapies and probiotics will be allowed if on stable ...

10. Histamine H2 Antagonist (Oral Route, Injection Route, Intravenous Route) Proper Use - Mayo Clinic

    These may be signs of a serious condition that may need different treatment. For patients taking the prescription strengths of these medicines for more serious ...